Skip to main content

Velphoro FDA Approval History

FDA Approved: Yes (First approved November 27, 2013)
Brand name: Velphoro
Generic name: sucroferric oxyhydroxide
Dosage form: Chewable Tablets
Company: Vifor Fresenius Medical Care Renal Pharma
Treatment for: Hyperphosphatemia of Renal Failure

Velphoro (sucroferric oxyhydroxide) is a chewable, iron-based phosphate binder for the control of serum phosphorus levels in patients with Chronic Kidney Disease (CKD) on dialysis.

Development timeline for Velphoro

Nov 30, 2013Approval Velphoro Receives US FDA Approval for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.